My First Cancer

The diagnosis that transformed my life came five years ago today.

I was vacationing, driving east on I-10, toward Tucson, when my cell phone broke the monotony of interstate pavement. It was the urologist who had done my prostate biopsy; we had played phone tag for several days, the apparent lack of urgency giving me a confident calm. I took an exit ramp, pulled to a stop and, old newspaper reporter that I am, began taking notes.

“There’s a little bit of cancer,” he said. What?! He gave me the title of a book to read so I could ask intelligent questions about my first cancer, as well as understand his answers. No sense discussing my Gleason Score unless I knew what it measures and what it means. “Read the book, and we’ll talk Friday.”

At a Barnes & Noble in Tucson, I searched the next morning for the book but finally had to ask for help: “Do you have Dr. Patrick Walsh’s Guide to Surviving –”

The rest of the title, Prostate Cancer, never came out. I had choked, both vocally and mentally. For it was only upon uttering Surviving that I fully grasped what I had been handed: a disease with the potential to kill me.

Five years following diagnosis is a milestone in cancer survival, and while it is a good deal for me personally, it is also a Big Deal: Virtually all of us who were diagnosed with prostate cancer in 2007 have so far survived the disease, thanks to earlier diagnosis and better treatments. So much so that there’s a kerfuffle today over whether prostate cancer is over-diagnosed and over-treated. In other words, many men (most?) will die with the disease, not from it. There’s just no way yet of telling early on who needs treatment and who doesn’t.

And me? I remain grateful that I was diagnosed. Diagnosis and surgery led to the discovery that my prostate cancer had taken up residence in nearby lymph nodes, warranting more aggressive treatment and more frequent check-ups. I’ve now had an experimental drug, surgery, hormone therapy and radiation accompanied by more hormone therapy. Over-treated? Not me.

I take whatever they have to offer, whatever will help me at each turn of the cancer screw — that’s Bill Curry’s guide to surviving prostate cancer.

Here’s to the next five.

 

Havana Classroom, 2010

Today marked three months since my completion of salvage radiation. “Has it been three months already?” they asked me at the check-in desk in Radiation Oncology at the Seattle Cancer Care Alliance.  I was reporting for a routine, follow-up visit with my radiation oncologist to attend to any lingering side effects since radiation’s end (none to report, knock on wood). It was brief, friendly and, in retrospect, almost remarkable for its lack of any mention of cancer. In short order, I was on my way.

It wasn’t until later, at Sea-Tac International Airport, that cancer raised its head.

I’m on my way back to Cuba, and I had given this absolutely no thought until, there I was, at the tail of the security line, gazing into a queue of passengers being herded to the whole-body security scanners.

I’ve tried to follow both the science and the scandal surrounding these devices, and while, at the bottom line of the science, there may be inconclusiveness about their safety, I reacted very simply: more radiation. And I’ve now had a lifetime’s worth. An X-ray for medical purposes, I understand and accept, and even for a dental exam, I’m fine – but for this? The two words reverberated: more radiation.

A touch of urgency set in. My failure to think this through beforehand was now forcing an impulsive decision: Can I refuse? How? And what’s my alternative? What exactly had I read in the news? And on the blogs — what had my fellow cancerians warned about these scanners? Why were they banned in Europe? Why hadn’t I thought of this?

Time was up. Time to declare my intentions or proceed to more radiation. No! I told myself, and then, with conviction to the TSA officer: “I need a non-radiation alternative.” I was cautioned about the sole alternative, a physical pat down. “Fine.”

“Step over there.” And over there, starting at my collar, blue latex hands began their inquisitive journey, down my torso, front and back, around and inside my waistband, and finally down my thighs, knees, calves, shins, to my very socks, the blue hands hijacking my every sense: I remember seeing and hearing nothing of the airport around me. The TSA officer was polite, official, thorough. And I was done.

Not yet. The officer’s blue latex gloves now needed to be checked for any explosive residue gleaned from my clothing. I stood alone, my shoeless feet aligned on a yellow +. Curious travelers passed, their eyes aiming unspoken questions at me. They hurried on.

And this, I thought, is my new normal.

Predator

I’m on my own now.

On Oct 17, I had my final three-month injection of hormone suppressant. So any day now, the side effects (hot flashes, chemo-brain and fatigue) should start ebbing, and testosterone should start flooding. The problem is, testosterone fuels the growth of prostate cancer, so now also begins the big wait-and-see, the medical equivalent of Neighborhood Watch, an anxious lookout for something to go wrong: recurrence.

A diagnosis of cancer is an ambush. Recurrence is predation in the night, a stalking, circling menace, unseen but sensed and feared — yet not fully realized until the pounce.

I’ve yet to meet a cancer survivor who doesn’t have at least a farthing of fear of recurrence. We all sense this menace, and it changes us and how we approach the very notion of time. We condition our present with a parenthetical (for now), and we hedge our future with a conditional “if all goes well.” We don’t talk of being “cured,” just that there’s “no evidence of disease.” Some survivors even animate recurrence: “the bear in the back room,” my friend Sandi calls it, waiting to break out.

These are the altars of language we kneel before to pay homage to Truth: With one routine test, our cancer circumstance can abruptly change — and with it our lives.

For prostate cancer survivors like me, it’s the PSA test that brings a slowly ratcheting anxiety, but all strains of cancer have follow-up tests or scans of their own, and all cancerians know the accompanying tension: the dread that the results will — this time — bring that feared change in circumstance. I finished my first round of hormone therapy in Oct 2009 and for nine fleeting months tested negative: no evidence of disease. But on July 12, 2010, with just five words, my cancer circumstance was abruptly changed. “Your PSA is not undetectable,” they said. PSA, a blood-marker of prostate cancer, had returned.

The predator had pounced.

Recurrence shook me. All the important things I’d been diligent about, all my strategies for pushing back, now seemed trivial, almost wasted, and I was reminded, one more time, that cancer is a disease and a metaphor for loss of control. It hadn’t mattered what I’d done. The cancer that had metastasized to my lymph nodes prior to surgery — even before diagnosis? — had endured.

A small voice within whispered, “You’re in trouble.” This was proving to be a more difficult contest with cancer than I’d foreseen, hoped or assumed. I doubled down on diet, exercise and nutrition, and I began seeing a naturopathic oncologist. I also began paying closer attention to new drugs in testing and coming to market: Which one, I muse, could someday become a vital part of my life?

Eventually, recurrence led to my recent round of salvage radiation, a one-off attempt to see if, finally, we could root out — even just suppress for a few years — the cancer that’s eluded all prior attempts. On Jan 23, I’ll have my first quarterly PSA check since radiation and, after that, quarterly tests for as far as the eye can wait-and-see: April…July…October…January. Lather, rinse, repeat.

But today, no pills, no injections, no radiation — I’m off treatment and on my own (for now).

Team SCCA: Patient with radiation therapists (L to R) Tony, Jason, Lorena

My 36 radiation treatments ended today, and we marked the occasion at Seattle Cancer Care Alliance with thank-yous, good-lucks, handshakes, a hug and a team photo of patient and therapists. In the cheer of it all, I felt the sadness of separation. I was the teammate who got traded. They stay together, and I move on. I’ll miss them.

Later, there was champagne at home (thank you, Craig). It was nothing, really, you’d call a big celebration, just a marking of the occasion with a toast and some of France’s best: one more cancer therapy, now completed.

Radiation seemed to go well — if you ignore the fact that there’s no way of knowing (yet) whether it “worked.” I asked how/when we’ll know if the radiation did me any good. The answer: When

• I’m done with hormone suppression (in January);
• my testosterone has returned to normal (about July);
• and I’ve no detectable PSA,

then it worked!

Translation: not any time soon.

In fact, I hope it takes years — decades, even — to know. For the longer I go without PSA, the likelier the radiation worked its magic. I don’t know if there’s an end point where someone will announce, “It worked!” It will more likely be just three months at a time as I pinball from one PSA test to the next. We should, though, get some idea over the next few years whether my PSA, and thus my cancer, are ever to come back.

(Because I’ll be making increasingly frequent, and increasingly important, references to PSA in these posts, I’ve created a petite primer on PSA and where it fits in my health care — the PSA & Me link, above, if you’re inclined).

I do remind myself that salvage radiation was never held out to me as a slam-dunk “cure.” I knew, and I know, viscerally and intellectually, that radiation was never a solid certainty — nor was it a hollow hope. It was somewhere in the scheme of possibility, but, like whack-a-mole, the greater probability is that my cancer will pop up again.

In short, I never saw radiation as the silver bullet. It was always an uncertain arrow in the oncologic quiver.

And it has now been spent.

I shot an arrow into the air;

It fell to earth I know not where.

–Longfellow

Lupron: Kim, mixing it up -- and getting the lumps out

A full afternoon at the Seattle Cancer Care Alliance today: the daily radiation treatment, the weekly visit with the radiation oncologist, the quarterly check-in with my oncologist.

• PSA test results came in at “undetectable,” which you’d largely expect, given my hormone-suppression therapy. Prior reading, in July, which was pre-hormone therapy, was 0.11. So that means PSA is down.
• Radiation treatment #20 — check that box. I’m now solidly past the halfway point on the way to 36.
• Another Lupron injection, which, with my Casodex pills, will keep my testosterone fully suppressed for the next three months. Upside: hot flashes in winter.
• My oncologist said today’s Lupron shot would be the last for now. I’ll see him again in January for a quarterly check-up and a PSA test — but no more Lupron and no more Casodex after that.
• And my radiation oncologist said he’s happy, which makes me happy, too. I reported to him that the few side effects from my salvage radiation have, so far, been mild and manageable.

And what, exactly, is salvage radiation? Bob Grindeland posed the question in his comment on my prior post, and that set me off to find an answer. I realized that while it’s a term I’ve heard, read and even used, I’d never pursued a medical definition. After all, “salvage” seemed to convey so much. Maybe even too much: say, the image of saving a ship from being battered on the rocks. But since Bob asked, here goes…

The National Cancer Institute defines salvage as “treatment that is given after the cancer has not responded to other treatments” — in my case, surgery.

The dictionary definition of salvage is more in the vernacular: “the rescue of property or material from potential loss or destruction.” Like salvaging a ship from being battered on the rocks.

Or salvaging me from cancer.